Glaucoma progression during the COVID-19 pandemics

<p> <b>V.E. Korelina<sup>1</sup>, I.R. Gazizova<sup>2</sup>, A.V. Kuroyedov<sup>3,4</sup>, M.D. Didur<sup>2</sup></b> </p> <p> <b><sup>1</sup>LLC “American Medical Clinic”, St. Petersburg, Russian Feder...

Full description

Saved in:
Bibliographic Details
Main Authors: V.E. Korelina, I.R. Gazizova, A.V. Kuroyedov, M.D. Didur
Format: Article
Language:Russian
Published: Prime-Media 2021-09-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/725/725c34fc54e20104ca4496a6141e228e.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526876390031360
author V.E. Korelina
I.R. Gazizova
A.V. Kuroyedov
M.D. Didur
author_facet V.E. Korelina
I.R. Gazizova
A.V. Kuroyedov
M.D. Didur
author_sort V.E. Korelina
collection DOAJ
description <p> <b>V.E. Korelina<sup>1</sup>, I.R. Gazizova<sup>2</sup>, A.V. Kuroyedov<sup>3,4</sup>, M.D. Didur<sup>2</sup></b> </p> <p> <b><sup>1</sup>LLC “American Medical Clinic”, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>2</sup>N.P. Bekhtereva Institute of the Human Brain, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>3</sup>P.V. Mandryka Military Clinical Hospital, Moscow, Russian Federation</b> </p> <p> <b><sup>4</sup>Pirogov Russian National Research Medical University, Moscow, Russian Federation</b> </p> <p> <i>The novel coronavirus infection (COVID-19) provides powerful effects on all pathogenic aspects of the primary open-angle glaucoma (POAG). The property of this virus to initiate disseminated intravascular coagulation, damage endotheliocytes, and impair coagulation result in&nbsp;numerous severe complications affecting all organs and systems. This disorder provokes retinal ischemia and hypoxia and spurs apoptosis of ganglionic cells. Cytokine storm and oxidative stress resulting from the COVID-19 potentially contribute to the progression of glaucomatous optic neuropathy. Distressing effect of the pandemic, a growing number of patients with depressive and anxiety disorders increase the risk of&nbsp;POAG and ocular hypertension, reduce treatment compliance, and exacerbate glaucoma course.</i> </p> <p> <i>Ophthalmic patients should be informed on potential risks and consequences of the COVID-19 and educated on the safety and efficacy of&nbsp;vaccination and the need for these preventive measures for elderly patients (in particular, with glaucoma).</i> </p> <p> <i>A year of the COVID-19 pandemic has radically changed the attitude to many processes&nbsp; of doctor-patient relationships. There is a need for the development of the technologies of distant monitoring of patients with glaucoma.</i> </p> <p> <i><b>Keywords</b>: primary open-angle glaucoma, COVID-19, telemedicine, pandemic, SARS-CoV-2, cytokine storm, oxidative stress, intraocular pressure, apoptosis of ganglionic cells, glaucomatous optic neuropathy, post-COVID-19 syndrome.</i> </p> <p> <i><b>For citation: </b>Korelina V.E., Gazizova I.R., Kuroyedov A.V., Didur M.D. Glaucoma progression during the COVID-19 pandemics. Russian Journal of Clinical Ophthalmology. 2021;21(3):147–152 (in Russ.). DOI: 10.32364/2311-7729-2021-21-3-147-152.</i> </p>
format Article
id doaj-art-4ded8fe768f0447b83d5ce319739281c
institution Kabale University
issn 2311-7729
2619-1571
language Russian
publishDate 2021-09-01
publisher Prime-Media
record_format Article
series РМЖ "Клиническая офтальмология"
spelling doaj-art-4ded8fe768f0447b83d5ce319739281c2025-01-16T09:39:38ZrusPrime-MediaРМЖ "Клиническая офтальмология"2311-77292619-15712021-09-0121331328Glaucoma progression during the COVID-19 pandemicsV.E. Korelina0I.R. Gazizova1A.V. Kuroyedov2M.D. Didur3Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> <b>V.E. Korelina<sup>1</sup>, I.R. Gazizova<sup>2</sup>, A.V. Kuroyedov<sup>3,4</sup>, M.D. Didur<sup>2</sup></b> </p> <p> <b><sup>1</sup>LLC “American Medical Clinic”, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>2</sup>N.P. Bekhtereva Institute of the Human Brain, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>3</sup>P.V. Mandryka Military Clinical Hospital, Moscow, Russian Federation</b> </p> <p> <b><sup>4</sup>Pirogov Russian National Research Medical University, Moscow, Russian Federation</b> </p> <p> <i>The novel coronavirus infection (COVID-19) provides powerful effects on all pathogenic aspects of the primary open-angle glaucoma (POAG). The property of this virus to initiate disseminated intravascular coagulation, damage endotheliocytes, and impair coagulation result in&nbsp;numerous severe complications affecting all organs and systems. This disorder provokes retinal ischemia and hypoxia and spurs apoptosis of ganglionic cells. Cytokine storm and oxidative stress resulting from the COVID-19 potentially contribute to the progression of glaucomatous optic neuropathy. Distressing effect of the pandemic, a growing number of patients with depressive and anxiety disorders increase the risk of&nbsp;POAG and ocular hypertension, reduce treatment compliance, and exacerbate glaucoma course.</i> </p> <p> <i>Ophthalmic patients should be informed on potential risks and consequences of the COVID-19 and educated on the safety and efficacy of&nbsp;vaccination and the need for these preventive measures for elderly patients (in particular, with glaucoma).</i> </p> <p> <i>A year of the COVID-19 pandemic has radically changed the attitude to many processes&nbsp; of doctor-patient relationships. There is a need for the development of the technologies of distant monitoring of patients with glaucoma.</i> </p> <p> <i><b>Keywords</b>: primary open-angle glaucoma, COVID-19, telemedicine, pandemic, SARS-CoV-2, cytokine storm, oxidative stress, intraocular pressure, apoptosis of ganglionic cells, glaucomatous optic neuropathy, post-COVID-19 syndrome.</i> </p> <p> <i><b>For citation: </b>Korelina V.E., Gazizova I.R., Kuroyedov A.V., Didur M.D. Glaucoma progression during the COVID-19 pandemics. Russian Journal of Clinical Ophthalmology. 2021;21(3):147–152 (in Russ.). DOI: 10.32364/2311-7729-2021-21-3-147-152.</i> </p>http://clinopht.com/upload/iblock/725/725c34fc54e20104ca4496a6141e228e.pdf
spellingShingle V.E. Korelina
I.R. Gazizova
A.V. Kuroyedov
M.D. Didur
Glaucoma progression during the COVID-19 pandemics
РМЖ "Клиническая офтальмология"
title Glaucoma progression during the COVID-19 pandemics
title_full Glaucoma progression during the COVID-19 pandemics
title_fullStr Glaucoma progression during the COVID-19 pandemics
title_full_unstemmed Glaucoma progression during the COVID-19 pandemics
title_short Glaucoma progression during the COVID-19 pandemics
title_sort glaucoma progression during the covid 19 pandemics
url http://clinopht.com/upload/iblock/725/725c34fc54e20104ca4496a6141e228e.pdf
work_keys_str_mv AT vekorelina glaucomaprogressionduringthecovid19pandemics
AT irgazizova glaucomaprogressionduringthecovid19pandemics
AT avkuroyedov glaucomaprogressionduringthecovid19pandemics
AT mddidur glaucomaprogressionduringthecovid19pandemics